Great Point Partners LLC Novo Cure LTD Transaction History

Great Point Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $22.8 Million - $37.4 Million	-713,998 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $783,737 - $1.26 Million	-39,483 Reduced 5.24%	713,998 $22.3 Million
Q1 2018 May 14, 2018	SELL	$19.3 - $23.65 $2.43 Million - $2.98 Million	-125,805 Reduced 14.31%	753,481 $0
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $11.4 Million - $15.4 Million	701,620 Added 394.91%	879,286 $17.8 Million
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $3.21 Million - $3.86 Million	177,666	177,666 $3.53 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.